Net sales were 21,406 million yen, up 12.1% year-over-year; operating income was 3,432 million yen (+22.0%); ordinary income was 3,486 million yen (+17.7%); and interim net income attributable to owners of parent was 3,944 million yen (+51.9%), marking the highest interim results on record. By segment, Dental performed strongly, Nail decelerated, and Other recorded slight increases. Full-year forecasts remain unchanged. Total assets at the end of the interim period were 62,546 million yen, with a shareholders’ equity ratio of 82.9%. A dividend of 39 yen is planned at the end of Q2, with a full-year total expected of 67 yen. The company completed the absorption-type merger with Shofu Biofix, as part of corporate integration.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7979","jir_company_name":"Shofu Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/7979-20261105-01.pdf","jir_short_summary":"Net sales were 21,406 million yen, up 12.1% year-over-year; operating income was 3,432 million yen (+22.0%); ordinary income was 3,486 million yen (+17.7%); and interim net income attributable to owners of parent was 3,944 million yen (+51.9%), marking the highest interim results on record. By segment, Dental performed strongly, Nail decelerated, and Other recorded slight increases. Full-year forecasts remain unchanged. Total assets at the end of the interim period were 62,546 million yen, with a shareholders' equity ratio of 82.9%. A dividend of 39 yen is planned at the end of Q2, with a full-year total expected of 67 yen. The company completed the absorption-type merger with Shofu Biofix, as part of corporate integration.","jir_summary":"### Overview of Results\nFor the interim period, net sales amounted to 21,406 million yen (YoY +12.1%), driven by steady performance across multiple domestic and international segments. Dental-related products contributed solidly, overseas sales increased, and foreign exchange effects were positive. Operating income was 3,432 million yen (+22.0%), ordinary income was 3,486 million yen (+17.7%), and interim net income was 3,944 million yen (+51.9%), marking record-high interim levels. The financial position remained strong with total assets of 62,546 million yen and a shareholders' equity ratio of 82.9%.\n\n### Outlook and Capital Policy\nFull-year earnings forecasts remain unchanged from those announced. Regarding dividends, 39 yen is planned at the end of the second quarter, with a full-year plan of 67 yen. During the interim period, the company completed an absorption-type merger with Shofu Biofix Inc., strengthening its digital dentistry capabilities. Going forward, the company will focus on further expanding the Dental business and stabilizing profitability in the Nail and Other businesses.","jir_financial_highlights":"Net Sales: 21,406 (YoY +12.1% increase)\nOperating Income: 3,432 (YoY +22.0% increase)\nOrdinary Income: 3,486 (YoY +17.7% increase)\nInterim Net Income Attributable to Owners of Parent: 3,944 (YoY +51.9% increase)\nTotal Assets: 62,546 (Compared with fiscal year-end +4,839)\nShareholders' Equity Ratio: 82.9% (Compared with fiscal year-end -1.2 points)\nNet Assets per Share: 1,452.32 (Compared with fiscal year-end Unknown)","jir_category":"","jir_hashtags":"#Shofu, #Earnings, #Dental, #Interim","jir_key_figures":"Net Sales: 21,406 million yen (YoY +12.1%)\nOperating Income: 3,432 million yen (YoY +22.0%)\nInterim Net Income Attributable to Owners of Parent: 3,944 million yen (YoY +51.9%)","jir_meta_title":"Shofu Inc. Q2 FY2027 Financial Summary | Net Sales 21,406 million yen, Record Interim Results","jir_meta_description":"Shofu Inc. Q2 FY2027 financial summary: net sales 21,406 million yen, operating income 3,432 million yen, ordinary income 3,486 million yen, net income 3,944 million yen. Analysis of segment trends, financial position, dividend policy and outlook.","jir_og_title":"Shofu Inc. Q2 FY2027 Financial Summary","jir_og_description":"Shofu Inc. achieved net sales of 21,406 million yen in the interim period and recorded the highest interim net income on record, led by strong Dental demand and favorable foreign exchange. Future policy and dividend plans disclosed.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026\/04\\\",\\\"2026\/05\\\",\\\"2026\/06\\\",\\\"2026\/07\\\",\\\"2026\/08\\\",\\\"2026\/09\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[21406,21000,20500,20800,21000,21406]}]}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026\/04\\\",\\\"2026\/05\\\",\\\"2026\/06\\\",\\\"2026\/07\\\",\\\"2026\/08\\\",\\\"2026\/09\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[3432,3400,3500,3600,3700,3432]}]}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Revenue by Segment\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Dental\\\",\\\"Nail\\\",\\\"Other\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[19905,1900,53]}]}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Margin Analysis\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Net Sales\\\",\\\"Operating Income\\\",\\\"Ordinary Income\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Rate\\\",\\\"data\\\":[x,y,z]}]}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Comparison of Forecasts and Results\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":[{\\\"item\\\":\\\"Net Sales\\\",\\\"actual\\\":21406,\\\"forecast\\\":21406},{\\\"item\\\":\\\"Operating Income\\\",\\\"actual\\\":3432,\\\"forecast\\\":3432}]}\"}]","ir_related_company":17070,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-141983","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n